Global Clinical Diagnostics Market to Reach US$ 143.8 Billion by 2032, Stimulated by the Increasing Prevalence of Chronic Illnesses

September 07, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Clinical Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” the global clinical diagnostics market size reached US$ 81.6 Billion in 2023. Clinical diagnostics refers to a wide spectrum of laboratory tests and examinations designed to detect, diagnose, and monitor diseases, medical conditions, and physiological abnormalities. These vital tests range from simple blood and urine assessments to intricate molecular diagnostic studies. By evaluating and analyzing bodily fluids, tissues, and other biological samples, clinical diagnostics provide essential information that assists healthcare professionals in making accurate, informed decisions about patient treatment and care. They are utilized in hospitals, laboratories, and healthcare facilities worldwide; clinical diagnostics play a crucial role in preventative health management, early detection of ailments, and personalized therapeutic strategies. They represent a fundamental component of modern medical practice and are integral to achieving improved patient outcomes, safety, and quality of life.

Global Clinical Diagnostics Market Trends:

The global clinical diagnostics market is experiencing significant growth, propelled by the escalating incidence of chronic illnesses including diabetes, cancer, and heart conditions. This is driving the demand for precise and early diagnostics. Concurrently, technological advancements in diagnostic techniques, such as Next-Generation Sequencing (NGS) and real-time PCR, are bolstering market expansion. Along with this, the rise in healthcare expenditure and investment in research and development is fostering innovation and efficiency in clinical diagnostics. In addition, the growing awareness of personalized medicine and targeted therapies is influencing the market positively. On the regulatory front, supportive governmental policies and increased funding are encouraging the adoption of sophisticated diagnostic methods. Apart from this, the COVID-19 pandemic has amplified the importance of rapid, accurate testing, highlighting the essential role of clinical diagnostics in public health. In confluence with this, the emerging trend towards home-based testing and telemedicine is also paving the way for a more patient-centric approach. Furthermore, the pursuit of eco-friendly practices and sustainability in laboratories is shaping the future direction of the industry. Collectively, these dynamics are setting a robust foundation for continued growth and innovation in the market, emphasizing its critical function in contemporary healthcare systems. Looking forward, the market value is projected to reach US$ 143.8 Billion by 2032, expanding at a CAGR of 6.4% during 2024-2032.

Market Summary:

  • Based on the test, the market has been segmented into lipid panel, liver panel, renal panel, complete blood count, electrolyte testing, infectious disease testing, and others.
  • On the basis of the product, the market is segregated into instruments, reagents, and others.
  • Based on the end user, the market has been segmented into hospital laboratory, diagnostic laboratory, point-of-care testing, and others.
  • Region-wise, the market has been segmented into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Qiagen N.V., Quest Diagnostics Incorporated, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific Inc.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Test, Product, End User, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Qiagen N.V., Quest Diagnostics Incorporated, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Clinical Diagnostics Market to Reach US$ 143.8 Billion by 2032, Stimulated by the Increasing Prevalence of Chronic Illnesses
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More